Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide effects on brown adipose tissue activity and energy expenditure in healthy young men
NL-OMON46200Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of exenatide, sponsored by Leiden University Medical Center. Primary endpoints: Brown adipose tissue activity by 18F-FDG PET-CT and MRI and Energy expenditure by indirect calorimetry. Started Sep 2016; status: active, not recruiting.
02
Drugs
exenatide
Beyond the preview
Go deeper on NL-OMON46200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46200.